The shares of Cooper Companies (The) (NYSE:COO) traded with a loss of -0.08 points or -0.05% in the most recent session. The shares last traded at $163.16. As per the trading info, the shares saw $0.8 million in upticks and lost $0.13 million in downticks, resulting in a net money flow of $0.67 million. The up/down ratio for the day was measured at 6.13. For the week, the shares had posted -1.35%.
Currently the company Insiders own 2.2% of Cooper Companies (The) shares according to the proxy statements. On the companys insider trading activities, Bender A Thomas, director of Cooper Companies Inc, unloaded 4,000 shares at an average price of $164.19 on June 6, 2016. The total amount of the transaction was worth $656,760, according to the disclosed information with the Securities and Exchange Commission in a Form 4 filing.
Cooper Companies (The) (NYSE:COO) stock ended Monday session in the red zone in a volatile trading. The stock closed down 0.92 points or 0.56% at $162.32 with 314,803 shares getting traded. Post opening the session at $163.05, the shares hit an intraday low of $162.02 and an intraday high of $164.5 and the price was in this range throughout the day. The company has a market cap of $7,864 million and the number of outstanding shares have been calculated to be 48,448,341 shares. The 52-week high of Cooper Companies (The) (NYSE:COO) is $181.73 and the 52-week low is $119.28.
Many analysts have stated their opinion on the company shares. Equity analysts at the Brokerage firm Jefferies maintains its rating on Cooper Companies (The) (NYSE:COO). The rating major has initiated the coverage with buy rating on the shares. The Analysts at Jefferies raises the price target from $175 per share to $190 per share. The rating by the firm was issued on June 3, 2016.
The Cooper Companies, Inc. (Cooper), is a global medical device company. The Company operates through two business units, CooperVision, Inc. (CVI) and CooperSurgical, Inc. (CSI). CooperVision is a global manufacturer providing products for contact lens wearers. CooperSurgical focuses on supplying womens health clinicians with products and treatment options to improve the delivery of healthcare to women. CooperSurgical products fall into three main segments based on the point of healthcare delivery: Hospital, Office and Fertility Clinic. CooperVision develops, manufactures and markets a range of monthly, two-week and single-use contact lenses, featuring advanced materials and optics. CooperVision is involved in correcting vision problems such as astigmatism, presbyopia and ocular dryness, and provides innovative contact lens solutions. The CooperVision Companys brands include Biofinity, Avaira and MyDay and CooperSurgical Companys brands include Advincula Arch, SeeClear and Mobius.